medigraphic.com
ISSN 0185-3252 (Print)
Revista de la Asociación Médica del Centro Médico ABC

2009, Number 2

<< Back Next >>

An Med Asoc Med Hosp ABC 2009; 54 (2)

Cutaneous manifestations in transplant patients

Frías AG

Language: Spanish
References: 26
Page: 88-96
PDF size: 117.92 Kb.


ABSTRACT

Long term survival after solid organ transplantation has compelled clinicians to obtain a better knowledge of dermatological reactions which can be an early marker of rejection, high risk of morbidity, or even mortality.


REFERENCES

  1. Palacio et al. A new arenavirus in transplantation. New Engl J Med 2008; 358: 2638-2639.

  2. 2 Glover MT, Niranjam N, Kwan J, Leigh IM. Warts and skin cancer in renal allograft recipients: The extent of the problem and a strategy for management. Br J Plast Surg 1994; 47: 86-89.

  3. Leigh IM, Glover MT. Cutaneous warts and tumours in immunosuppressed patients. J R Soc Med 1995; 88: 61-62.

  4. Stockfleth E, Nindl I, Sterry W, Ulrich C, Schmook T, Meyer T. Human papillomaviruses in transplant-associated skin cancers. Dermatol Surg 2004; 30 (4): 604-609.

  5. Bonatti H, Aigner F, De Clercq E, Boesmueller C, Widschwendner A, Larcher C, Margreiter R, Schneeberger S. Local administration of cidofovir for human papilloma virus associated skin lesions in transplant recipients. Transpl Int 2007; 20 (3): 238-246.

  6. 6 Karagas MR, Nelson HH, Sehr P, Waterboer T, Stukel TA, Andrew A, Green AC, Bavinck JN, Perry A, Spencer S, Rees JR, Mott LA, Pawlita M. Human papillomavirus infection and incidence of squamous cell and basal cell carcinomas of the skin. J Natl Cancer Inst 2006; 98 (19): 1425-1426.

  7. Arness T, Pedersen R, Dierkhising R, Kremers W, Patel R. Varicella zoster virus-associated disease in adult kidney transplant recipients: incidence and risk-factor analysis. Transpl Infect Dis 2008; 10 (4): 260-268.

  8. Steer CB, Szer J, Sasadeusz J, Matthews JP, Beresford JA, Grigg A. Varicella-zoster infection after allogeneic bone marrow transplantation: Incidence, risk factors and prevention with low-dose aciclovir and ganciclovir. Bone Marrow Transplant 2000; 25 (6): 657-664.

  9. Choi YL, Kim JA, Jang KT, Kim DS, Kim WS, Lee JH, Yang JM, Lee ES, Lee DY. Characteristics of cutaneous cytomegalovirus infection in non-acquired immune deficiency syndrome, immunocompromised patients. Br J Dermatol 2006; 155 (5): 977-982.

  10. Rawle PHF, Kim K, Chun D. Cervical tuberculosis (scrofula) a case report. J Oral Maxillofaci Surg 2004; 62: 94-97.

  11. Lattes R, Radisic M, Rial M, Argento J, Casadei D. Tuberculosis in renal transplant recipients. Transpl Infect Dis 1999; 1(2): 98-104.

  12. Pranatharthi Chandrasekar. Selection criteria for antifungals: The right patients and the right reasons. Intl J Antimicrobial Agents 2006; (27S): S17-S20.

  13. Gülec AT, Demirbilek M, Seckin D, Can F, Saray Y, Sarifakiog¡lu E, Mehmet H. Superficial fungal infections in 102 renal transplant recipients: A case-control study. J Am Acad Dermatol 2003; 49: 187-192.

  14. Sharpe MD, Ghent C, Grant D, Horbay GL, McDougal J, Colby DW. Efficacy and safety of itraconazole prophylaxis for fungal infections after orthotopic liver transplantation: A prospective, randomized, double-blind study. Transplantation 2003; 76 (6): 977-983.

  15. Husain S, Tollemar J, Dominguez E, Baumgarten K, Humar A, Paterson DL, Wagener M, Kusne M, Singh N. Changes in the spectrum and risk factors for invasive candidiasis in liver transplant recipients. Transplantation 2003; 75: 2023-2029.

  16. Al-Mohaya MA, Darwazeh A, Al-Khudair W. Oral fungal colonization and oral candidiasis in renal transplant patients: The relationship to Miswak use. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2002; 93: 455-460.

  17. Fortún Abete J, Martín-Dávila P. The role of anidulafungin therapy in solid organ transplant recipients. Rev Iberoam Micol 2008; 25 (2): 129-133.

  18. Ramsay HM, Reece SM, Fryer AA, Smith AG, Harden PN. Seven-year prospective study of non melanoma skin cancer incidence in U.K. Renal Transplant. Recipients Transpl 2007; 84: 437-439.

  19. Lindelof B, Sigurgeirsson B, Gabel H, Sten RS. Incidence of skin cancer in 5,356 patients following organ transplantation. Br J Dermatol 2000; 143: 513-519.

  20. Le Mire L, Hollowood K, Gray D, Bordea C, Wojnarowska F. Melanomas in renal transplant recipients. Br J Dermatol 2007; 156 (1): 165-167.

  21. Rodríguez-Gil Y, Palencia SI, López-Ríos F, Ortiz PL, Rodríguez-Peralto JL. Mycosis fungoides after solid organ transplantation: Report of 2 new cases. Am J Dermatopathol 2008; 30: 150-155.

  22. Salama S. Primary «Cutaneous» T-cell anaplastic large cell lymphoma, CD30+, neutrophil-rich variant with subcutaneous panniculitic lesions, in apost-renal transplant patient. Report of unusual case and literature review. Am J Dermatopathol 2005; 27: 217-223.

  23. McMullan D, Radovan B, Jackow CO, Frazier O, Duvic M. Cutaneous T-cell lymphoma in a cardiac transplant recipient. Tex Heart Inst J 2001; 28 (3): 203-207.

  24. Velásquez LMM. Enfermedad injerto contra huésped. Rev Inmunoalergia Asoc Col Aler Asma Inmunol 2001; 10-4: 110-119.

  25. Shin, Hong W, Song H, Choi G, Chan Kim Y. Atypical acute Graft-versus-Host disease. Am J Dermatopathol 2007; 29: 576-577.

  26. Häusermann P, Walter RB, Halter J, Biedermann BC, Tichelli A, Itin P, Gratwohl A. Cutaneous Graft-versus-Host disease: A guide for the dermatologist Dermatology 2008; 216: 287-304.




2020     |     www.medigraphic.com